Patterson has always advocated for the use of statins as an anti-inflammatory in both acute covid and long covid. However, with long covid at least, he advocates for a very low dose and for only as long as it takes to relieve the inflammation, not life-long usage.

He seems to feel that statins are especially good at dealing with fractalkine receptors on the endothelial layer of blood vessels. These are the receptors that can anchor non-classical monocyte macrophages to the endothelium, which is not so good, causing inflammation, especially in the blood vessels of the brain.

Through flow cytometry separation of blood components, he has found non-classical macrophages can and do display the S1 spike protein from the SAR2 virus and the RNA vaccines, keeping the immune system out of homeostasis, especially because once monocytes morph into non-classical macrophages, they become almost immortal cells instead of clearing out of the body in a matter of days.

Patterson originally was using Pravastatin with Maraviroc but changed to atorvastatin (Lipitor) because the FDA approved it more for pediatric use (I wonder why?).

If low dose statins do indeed help clear fractalkines and non-classical macrophages, perhaps they should be used with Leronlimab too.